Urbain Säwe

2.1k total citations
32 papers, 1.6k citations indexed

About

Urbain Säwe is a scholar working on Physiology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Urbain Säwe has authored 32 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 11 papers in Molecular Biology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Urbain Säwe's work include Smoking Behavior and Cessation (13 papers), Nicotinic Acetylcholine Receptors Study (10 papers) and Olfactory and Sensory Function Studies (3 papers). Urbain Säwe is often cited by papers focused on Smoking Behavior and Cessation (13 papers), Nicotinic Acetylcholine Receptors Study (10 papers) and Olfactory and Sensory Function Studies (3 papers). Urbain Säwe collaborates with scholars based in Sweden, Denmark and United Kingdom. Urbain Säwe's co-authors include Philip Tønnesen, C Feyerabend, G Gustavsson, Jesper Nørregaard, Michael A. Russell, Gareth Thomas, Michael A. Russell, Geraint T. Williams, Rupert Pullan and Robert G. Newcombe and has published in prestigious journals such as New England Journal of Medicine, The Journal of Urology and European Respiratory Journal.

In The Last Decade

Urbain Säwe

32 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Urbain Säwe Sweden 17 978 574 262 232 211 32 1.6k
Niklas Hartmann United States 17 514 0.5× 474 0.8× 171 0.7× 101 0.4× 71 0.3× 42 1.5k
Isaiah D. Wexler Israel 24 320 0.3× 546 1.0× 153 0.6× 133 0.6× 126 0.6× 76 1.8k
David Rabin United States 22 390 0.4× 332 0.6× 243 0.9× 143 0.6× 197 0.9× 33 2.2k
Christine L. Baker United States 19 644 0.7× 347 0.6× 162 0.6× 74 0.3× 68 0.3× 58 1.5k
A Fernández‐Cruz Spain 20 579 0.6× 271 0.5× 392 1.5× 163 0.7× 88 0.4× 59 1.8k
Kathryn Hirst United States 25 353 0.4× 152 0.3× 398 1.5× 224 1.0× 309 1.5× 50 1.7k
Sylvie Pinault Canada 8 1.0k 1.1× 172 0.3× 516 2.0× 399 1.7× 195 0.9× 10 2.0k
Gérard Reach France 22 312 0.3× 243 0.4× 136 0.5× 135 0.6× 97 0.5× 85 1.4k
Christina A. Mikosz United States 14 403 0.4× 313 0.5× 479 1.8× 281 1.2× 123 0.6× 30 1.6k
Éric Bertin France 23 471 0.5× 312 0.5× 115 0.4× 161 0.7× 263 1.2× 71 1.6k

Countries citing papers authored by Urbain Säwe

Since Specialization
Citations

This map shows the geographic impact of Urbain Säwe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Urbain Säwe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Urbain Säwe more than expected).

Fields of papers citing papers by Urbain Säwe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Urbain Säwe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Urbain Säwe. The network helps show where Urbain Säwe may publish in the future.

Co-authorship network of co-authors of Urbain Säwe

This figure shows the co-authorship network connecting the top 25 collaborators of Urbain Säwe. A scholar is included among the top collaborators of Urbain Säwe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Urbain Säwe. Urbain Säwe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bolliger, Chris T., Jean-Pierre Zellweger, Tobias Danielsson, et al.. (2002). Influence of long-term smoking reduction on health risk markers and quality of life. Nicotine & Tobacco Research. 4(4). 433–439. 70 indexed citations
2.
Fornai, E., Francesco Pistelli, Laura Carrozzi, et al.. (2001). Smoking reduction in smokers compliant to a smoking cessation trial with nicotine patch.. PubMed. 56(1). 5–10. 10 indexed citations
3.
Tønnesen, Philip, Paolo Paoletti, G Gustavsson, et al.. (1999). Higher dosage nicotine patches increase one‐year smoking cessation rates: results from the European CEASE trial. European Respiratory Journal. 13(2). 238–238. 194 indexed citations
4.
Lúðvíksdóttir, Dóra, et al.. (1999). Effects of nicotine nasal spray on atherogenic and thrombogenic factors during smoking cessation. Journal of Internal Medicine. 246(1). 61–66. 22 indexed citations
5.
Paoletti, Paolo, E. Fornai, Roberto Puntoni, et al.. (1996). Importance of baseline cotinine plasma values in smoking cessation: results from a double-blind study with nicotine patch. European Respiratory Journal. 9(4). 643–651. 97 indexed citations
6.
Johansson, Carl‐Johan, Per Olsson, Per Olov Gunnarsson, & Urbain Säwe. (1996). Pharmacokinetics of a 16-Hour Transdermal Nicotine Patch. Clinical Drug Investigation. 12(4). 198–206. 4 indexed citations
7.
Thomas, Gareth, S. Davies, J. Rhodes, et al.. (1995). Is Transdermal Nicotine Associated with Cardiovascular Risk?. Journal of the Royal College of Physicians of London. 29(5). 392–396. 28 indexed citations
8.
Pullan, Rupert, John Morris, Geraint T. Williams, et al.. (1994). Transdermal Nicotine for Active Ulcerative Colitis. New England Journal of Medicine. 330(12). 811–815. 387 indexed citations
9.
Tønnesen, Philip, et al.. (1993). Recycling with nicotine patches in smoking cessation. Addiction. 88(4). 533–539. 45 indexed citations
10.
Russell, Michael A., J A Stapleton, C Feyerabend, et al.. (1993). Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches.. BMJ. 306(6888). 1308–1312. 138 indexed citations
11.
Nørregaard, Jesper, Philip Tønnesen, Knud Simonsen, & Urbain Säwe. (1992). Long-term nicotine substitution after application of a 16-hour nicotine patch in smoking cessation. European Journal of Clinical Pharmacology. 43(1). 57–60. 12 indexed citations
12.
Nørregaard, Jesper, et al.. (1992). Smoking habits in relapsed subjects from a smoking cessation trial after one year. British Journal of Addiction. 87(8). 1189–1194. 16 indexed citations
13.
Tønnesen, Philip, et al.. (1991). A Double-Blind Trial of a 16-Hour Transdermal Nicotine Patch in Smoking Cessation. New England Journal of Medicine. 325(5). 311–315. 236 indexed citations
14.
Blombäck, Margareta, Per Olov Hedlund, & Urbain Säwe. (1988). Changes in blood coagulation and fibrinolysis in patients on different treatment regimens for prostatic cancer. - predictors for cardiovascular complications?. Thrombosis Research. 49(1). 111–121. 22 indexed citations
15.
Stern, Heiko, et al.. (1985). Cardiovascular Effects of Single Doses of the Antidepressants Amitriptyline and Lofepramine in Healthy Subjects*. Pharmacopsychiatry. 18(4). 272–277. 8 indexed citations
16.
Rössner, Stephan, Per Olov Hedlund, Tomas Jogestrand, & Urbain Säwe. (1985). Treatment of Prostatic Cancer: Effects on Serum Lipoproteins and the Cardiovascular System. The Journal of Urology. 133(1). 53–57. 18 indexed citations
17.
Nilsson, J., Christer Sjögren, & Urbain Säwe. (1984). The Effects of a Highly Purified Hyaluronidase Preparation on Experimental Myocardial Infarction in the Rat. Acta Medica Scandinavica. 216(2). 209–213. 2 indexed citations
18.
Theorell, Töres, Leif Erhardt, Evy Lind, A. Sjögren, & Urbain Säwe. (1975). Selected Psychosocial Variables in the Delay of Reaching the Coronary Care Unit. Acta Medica Scandinavica. 198(1-6). 315–317. 7 indexed citations
19.
Erhardt, Leif, A. Sjögren, Urbain Säwe, & Töres Theorell. (1974). PREHOSPITAL PHASE OF PATIENTS ADMITTED TO A CORONARY CARE UNIT. Acta Medica Scandinavica. 196(1-6). 41–46. 18 indexed citations
20.
Säwe, Urbain. (1972). Early diagnosis of acute myocardial infarction with special reference to the diagnosis of the intermediate coronary syndrome. A clinical study.. PubMed. 545. 1–76. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Niklas Hartmann Breakdown of academic impact, for papers by Isaiah D. Wexler Breakdown of academic impact, for papers by David Rabin Breakdown of academic impact, for papers by Christine L. Baker Breakdown of academic impact, for papers by A Fernández‐Cruz Breakdown of academic impact, for papers by Kathryn Hirst Breakdown of academic impact, for papers by Sylvie Pinault Breakdown of academic impact, for papers by Gérard Reach Breakdown of academic impact, for papers by Christina A. Mikosz Breakdown of academic impact, for papers by Éric Bertin
Rankless by CCL
2026